Azie NE - Search Results

1

Treatment and outcomes of invasive fusariosis: review of 65 cases from the PATH Alliance(®) registry.

Horn DL, Freifeld AG, Schuster MG, Azie NE, Franks B, Kauffman CA. Horn DL, et al. Among authors: azie ne. Mycoses. 2014 Nov;57(11):652-8. doi: 10.1111/myc.12212. Epub 2014 Jun 18. Mycoses. 2014. PMID: 24943384 Free article.

2

Epidemiology and outcomes of invasive candidiasis due to non-albicans species of Candida in 2,496 patients: data from the Prospective Antifungal Therapy (PATH) registry 2004-2008.

Pfaller MA, Andes DR, Diekema DJ, Horn DL, Reboli AC, Rotstein C, Franks B, Azie NE. Pfaller MA, et al. Among authors: azie ne. PLoS One. 2014 Jul 3;9(7):e101510. doi: 10.1371/journal.pone.0101510. eCollection 2014. PLoS One. 2014. PMID: 24991967 Free PMC article.

3

Prospective antifungal therapy (PATH) alliance(®) : focus on mucormycosis.

Kontoyiannis DP, Azie N, Franks B, Horn DL. Kontoyiannis DP, et al. Mycoses. 2014 Apr;57(4):240-6. doi: 10.1111/myc.12149. Epub 2013 Oct 22. Mycoses. 2014. PMID: 24147728

4

Epidemiological features of invasive mold infections among solid organ transplant recipients: PATH Alliance® registry analysis.

Husain S, Silveira FP, Azie N, Franks B, Horn D. Husain S, et al. Med Mycol. 2017 Apr 1;55(3):269-277. doi: 10.1093/mmy/myw086. Med Mycol. 2017. PMID: 27703022

5

Treatment and outcomes of Candida osteomyelitis: review of 53 cases from the PATH Alliance® registry.

Neofytos D, Huprikar S, Reboli A, Schuster M, Azie N, Franks B, Horn D. Neofytos D, et al. Eur J Clin Microbiol Infect Dis. 2014 Jan;33(1):135-41. doi: 10.1007/s10096-013-1939-0. Epub 2013 Aug 2. Eur J Clin Microbiol Infect Dis. 2014. PMID: 23907587

6

The PATH (Prospective Antifungal Therapy) Alliance® registry and invasive fungal infections: update 2012.

Azie N, Neofytos D, Pfaller M, Meier-Kriesche HU, Quan SP, Horn D. Azie N, et al. Diagn Microbiol Infect Dis. 2012 Aug;73(4):293-300. doi: 10.1016/j.diagmicrobio.2012.06.012. Diagn Microbiol Infect Dis. 2012. PMID: 22789847 Review.

7

Clinical epidemiology of 960 patients with invasive aspergillosis from the PATH Alliance registry.

Steinbach WJ, Marr KA, Anaissie EJ, Azie N, Quan SP, Meier-Kriesche HU, Apewokin S, Horn DL. Steinbach WJ, et al. J Infect. 2012 Nov;65(5):453-64. doi: 10.1016/j.jinf.2012.08.003. Epub 2012 Aug 13. J Infect. 2012. PMID: 22898389

8

The Prospective Antifungal Therapy Alliance(®) registry: A two-centre Canadian experience.

Haider S, Rotstein C, Horn D, Laverdiere M, Azie N. Haider S, et al. Can J Infect Dis Med Microbiol. 2014 Spring;25(1):17-23. doi: 10.1155/2014/308169. Can J Infect Dis Med Microbiol. 2014. PMID: 24634683 Free PMC article.

9

Clinical characteristics and outcomes in 303 HIV-infected patients with invasive fungal infections: data from the Prospective Antifungal Therapy Alliance registry, a multicenter, observational study.

Marukutira T, Huprikar S, Azie N, Quan SP, Meier-Kriesche HU, Horn DL. Marukutira T, et al. HIV AIDS (Auckl). 2014 Mar 13;6:39-47. doi: 10.2147/HIV.S53910. eCollection 2014. HIV AIDS (Auckl). 2014. PMID: 24648769 Free PMC article.

10

Hospital resource use of patients receiving isavuconazole vs voriconazole for invasive mold infections in the phase III SECURE trial.

Horn D, Goff D, Khandelwal N, Spalding J, Azie N, Shi F, Franks B, Shorr AF. Horn D, et al. J Med Econ. 2016 Jul;19(7):728-34. doi: 10.3111/13696998.2016.1164175. Epub 2016 Mar 30. J Med Econ. 2016. PMID: 26960060 Free article. Clinical Trial.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

49 results

Search Page

Filters